Axis Spine received $1 million (830,000 pounds) from three investors as it readies to advance its anterior spinal implant technology in the U.S., Business Leader reports.
Spinal Tech
The FDA on April 14 granted TDi 510(k) clearance for its SonoVision ultrasound system for spine surgery.
Biotechnology company CytoDyn told investors on April 13 that five patients with mild-to-moderate COVID-19 symptoms were able to get off oxygen after taking its leronlimab drug, Proactive Investors reports.
Johnson & Johnson reported a 7.5 percent drop in orthopedic sales during the first quarter of 2020, disrupted by the coronavirus.
Medicrea reported its full-year 2019 and first-quarter 2020 financial results, posting a $17 million (15.6 million euro) loss on the year.
Advertisement
Biotechnology company CytoDyn appointed Scott Kelly, MD, as CMO and head of business development on April 13.
A Barclays analyst cut her rating on Stryker amid the COVID-19 pandemic.
Orthopedic fixation company Ossio recently added former Johnson & Johnson executive Gary Pruden to its board of directors, Biospace reports.
Zimmer Biomet plans to drastically scale back operations for two weeks due to the COVID-19 pandemic, WANE 15 reports.
The global cervical total disc replacement devices market is expected to surpass $5.3 billion by 2027, demonstrating a compound annual growth rate of 21.7 percent, according to Coherent Market Insights.